A citation-based method for searching scientific literature

S Sha, D Polidori, T Heise, J Natarajan, K Farrell, S-S Wang, D Sica, P Rothenberg, L Plum-Mörschel. Diabetes Obes Metab 2014
Times Cited: 143



Despoina Vasilakou, Thomas Karagiannis, Eleni Athanasiadou, Maria Mainou, Aris Liakos, Eleni Bekiari, Maria Sarigianni, David R Matthews, Apostolos Tsapas. Ann Intern Med 2013
Times Cited: 518




List of shared articles



Times cited

Glucose Lowering Efficacy and Pleiotropic Effects of Sodium-Glucose Cotransporter 2 Inhibitors.
Mohammad Shafi Kuchay, Khalid Jamal Farooqui, Sunil Kumar Mishra, Ambrish Mithal. Adv Exp Med Biol 2021
4

Renal physiology of glucose handling and therapeutic implications.
David Z Cherney, Mehmet Kanbay, Julie A Lovshin. Nephrol Dial Transplant 2020
18


Control of 24-hour blood pressure with SGLT2 inhibitors to prevent cardiovascular disease.
Kazuomi Kario, Keith C Ferdinand, James H O'Keefe. Prog Cardiovasc Dis 2020
16




Sodium Glucose Co-transporter-2 Inhibitor: Benefits beyond Glycemic Control.
Manash Pratim Baruah, B M Makkar, Vikrant B Ghatnatti, Kaushik Mandal. Indian J Endocrinol Metab 2019
5

Review on sodium-glucose cotransporter 2 inhibitor (SGLT2i) in diabetes mellitus and heart failure.
Akshyaya Pradhan, Shweta Vohra, Pravesh Vishwakarma, Rishi Sethi. J Family Med Prim Care 2019
7

SGLT2 Inhibitors and Mechanisms of Hypertension.
Alexandros Briasoulis, Omar Al Dhaybi, George L Bakris. Curr Cardiol Rep 2018
33

Effects of sodium glucose co-transporter 2 inhibitors on the kidney.
Natalia de Albuquerque Rocha, Ian J Neeland, Peter A McCullough, Robert D Toto, Darren K McGuire. Diab Vasc Dis Res 2018
19

SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management.
Michaël J B van Baar, Charlotte C van Ruiten, Marcel H A Muskiet, Liselotte van Bloemendaal, Richard G IJzerman, Daniël H van Raalte. Diabetes Care 2018
74



SGLT-2 inhibitors: Their pleiotropic properties.
Natalia G Vallianou, Eleni Geladari, Christos E Kazazis. Diabetes Metab Syndr 2017
9

An evidence-based practice-oriented review focusing on canagliflozin in the management of type 2 diabetes.
Joseph A Messana, Stanley S Schwartz, Raymond R Townsend. Vasc Health Risk Manag 2017
5